Related Experiment Video
Updated: Jul 14, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Inflammatory mediators in gestational diabetes mellitus
Alvie C Richardson1, Marshall W Carpenter
1Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Women and Infants' Hospital of Rhode Island/Brown University School of Medicine, 3rd Floor, Providence, RI 02905, USA.
Obstetrics and Gynecology Clinics of North America
|June 19, 2007
Summary
Inflammation is linked to insulin resistance, a condition affecting many pregnancies. This review examines inflammatory mediators and their role in gestational diabetes mellitus.
Area of Science:
- Endocrinology
- Immunology
- Reproductive Medicine
Background:
- Insulin resistance is a key feature of metabolic disorders.
- Inflammation plays a critical role in the development of insulin resistance.
- Gestational diabetes mellitus (GDM) represents a significant public health concern during pregnancy.
Purpose of the Study:
- To comprehensively review the existing scientific literature.
- To elucidate the association between inflammatory mediators and GDM.
- To provide an updated understanding of the inflammatory pathways implicated in GDM pathogenesis.
Main Methods:
- Literature search of scientific databases (e.g., PubMed, Scopus).
- Inclusion of epidemiological and experimental studies.
- Synthesis of evidence on inflammatory markers and GDM.
Main Results:
- Consistent evidence links chronic inflammation with insulin resistance.
- Specific inflammatory mediators (e.g., cytokines) are implicated in GDM.
- Studies demonstrate a correlation between elevated inflammatory markers and GDM risk.
Conclusions:
- Inflammatory processes are integral to the pathophysiology of GDM.
- Targeting inflammation may offer novel therapeutic strategies for GDM prevention and management.
- Further research is warranted to fully understand the complex interplay between inflammation and GDM.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...